Funded Startups in Zwijnaarde
Seven funded startups are listed for Zwijnaarde, with round dates spanning 2020-07-27 (Indigo Diabetes) to 2026-06-17 (Bike Republic).
Seven funded startups are listed for Zwijnaarde, with round dates spanning 2020-07-27 (Indigo Diabetes) to 2026-06-17 (Bike Republic). The disclosed amounts are highly uneven: Aphea.Bio’s $77M (2023-07-11) is the only round above $50M, dwarfing the next-largest disclosed rounds at $42M (ExeVir Bio, 2020-07-28) and $38M (Indigo Diabetes, 2020-07-27). Sector clustering is also clear: four of the seven entries are in biotechnology (4Tissue, Aphea.Bio, RheaVita, ExeVir Bio), while the remaining sectors are Clothing and Apparel (Bike Republic), Food and Beverage (Those Vegan Cowboys), and Health Care (Indigo Diabetes).
The staging labels skew toward indeterminacy for recent deals: five of seven rows show “Series Unknown” or a blank series field (Bike Republic 2026-06-17, Those Vegan Cowboys 2025-12-18, RheaVita 2021-06-02, ExeVir Bio 2020-07-28, Indigo Diabetes 2020-07-27). Dates also cluster around mid-2020, where three entries fall within two days (Indigo Diabetes on 2020-07-27; ExeVir Bio on 2020-07-28).
Most recent rounds
7 shownRelated listings
Frequently asked
What stands out in Zwijnaarde by round size, and how does the top deal compare to the rest?
Aphea.Bio’s $77M round on 2023-07-11 is the only disclosed amount above $50M; the next-largest disclosed amounts are $42M (ExeVir Bio, 2020-07-28) and $38M (Indigo Diabetes, 2020-07-27). Most other disclosed rounds shown sit below that $40M–$50M band, including $7M (Those Vegan Cowboys, 2025-12-18) and $6M (Bike Republic, 2026-06-17).
How concentrated are sectors in this Zwijnaarde set?
Biotechnology dominates with 4 of 7 entries: 4Tissue ($1M, 2025-02-26), Aphea.Bio ($77M, 2023-07-11), RheaVita ($3M, 2021-06-02), and ExeVir Bio ($42M, 2020-07-28). The other 3 entries split across Clothing and Apparel (Bike Republic, $6M, 2026-06-17), Food and Beverage (Those Vegan Cowboys, $7M, 2025-12-18), and Health Care (Indigo Diabetes, $38M, 2020-07-27).
Are there noticeable time clusters among the most recent rounds shown?
Yes: three rounds land within a two-day window in 2020—Indigo Diabetes on 2020-07-27 ($38M) and ExeVir Bio on 2020-07-28 ($42M), with the list’s next-oldest date being 2021-06-02 for RheaVita ($3M). On the other side, the newest two disclosed rounds are tightly grouped in 2025–2026 (Those Vegan Cowboys on 2025-12-18 for $7M, followed by Bike Republic on 2026-06-17 for $6M).
What does the stage mix look like across these Zwijnaarde rounds?
“Series Unknown” or a blank series field appears in 5 of 7 rows: Bike Republic (2026-06-17, $6M), Those Vegan Cowboys (2025-12-18, $7M), RheaVita (2021-06-02, $3M), ExeVir Bio (2020-07-28, $42M), and Indigo Diabetes (2020-07-27, $38M). Only two rows provide stage labels—4Tissue is Seed ($1M, 2025-02-26) and Aphea.Bio is Series C ($77M, 2023-07-11).
Which entries are the main outliers by amount, and what are their sectors?
Two outliers by disclosed size are most apparent: Aphea.Bio’s $77M (2023-07-11) in Agriculture and Farming, and ExeVir Bio’s $42M (2020-07-28) in Biotechnology. The smallest disclosed amount shown is $1M for 4Tissue (2025-02-26, Biotechnology), which sits far below the top-$30M range entries (Indigo Diabetes at $38M on 2020-07-27 and ExeVir Bio at $42M on 2020-07-28).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.